|
|
Volumn 10, Issue 5, 2002, Pages 405-411
|
|
Rituximab, cyclophosphamide, dexamethasone (RCD) regimen induces cure in WSU-WM xenograft model and a partial remission in previously treated Waldenstrom's macroglobulinemia patient
a
|
|
Author keywords
Cyclophosphamide; Dexamethasone xenografts; Rituximab; SCID mice; Waldenstrom's macroglobulinemia
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CYCLOPHOSPHAMIDE;
DEXAMETHASONE;
DILUENT;
DIPHENHYDRAMINE;
HEMOGLOBIN;
HYDROCORTISONE;
IMMUNOGLOBULIN M;
PARACETAMOL;
PREDNISONE;
RITUXIMAB;
VINCRISTINE;
MONOCLONAL ANTIBODY;
ADULT;
ANIMAL CELL;
ANIMAL TISSUE;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
BONE MARROW METASTASIS;
CANCER CELL CULTURE;
CANCER COMBINATION CHEMOTHERAPY;
CANCER GROWTH;
CANCER INHIBITION;
CANCER PATIENT;
CANCER RECURRENCE;
CANCER REGRESSION;
CASE REPORT;
CLINICAL PROTOCOL;
CLINICAL STUDY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG ACTIVITY;
DRUG EFFICACY;
DRUG TOLERABILITY;
FEMALE;
HEMOGLOBIN DETERMINATION;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
IN VIVO STUDY;
LYMPHOPROLIFERATIVE DISEASE;
MONOTHERAPY;
NONHUMAN;
PRIORITY JOURNAL;
RANDOMIZATION;
SCID MOUSE;
STATISTICAL ANALYSIS;
THROMBOCYTE COUNT;
TREATMENT OUTCOME;
TUMOR MODEL;
TUMOR XENOGRAFT;
WALDENSTROEM MACROGLOBULINEMIA;
ANIMAL;
CELL DIVISION;
CELL LINE;
COMPARATIVE STUDY;
DISEASE MODEL;
DRUG COMBINATION;
DRUG EFFECT;
DRUG SCREENING;
INSTITUTE FOR CANCER RESEARCH MOUSE;
MIDDLE AGED;
MOUSE;
MOUSE MUTANT;
PATHOLOGY;
REMISSION;
ANIMALS;
ANTIBODIES, MONOCLONAL;
CELL DIVISION;
CELL LINE;
CYCLOPHOSPHAMIDE;
DEXAMETHASONE;
DISEASE MODELS, ANIMAL;
DRUG THERAPY, COMBINATION;
FEMALE;
HUMANS;
MICE;
MICE, INBRED ICR;
MICE, SCID;
MIDDLE AGED;
REMISSION INDUCTION;
WALDENSTROM MACROGLOBULINEMIA;
XENOGRAFT MODEL ANTITUMOR ASSAYS;
|
|
EID: 0035994305
PISSN: 1061186X
EISSN: None
Source Type: Journal
DOI: 10.1080/1061186021000001850 Document Type: Article |
|
Times cited : (10)
|
|
References (26)
|
